Advanced search
1 file | 649.39 KB

Radiosynthesis and in vivo evaluation of [18F] FABABA, a new ASCT-2 inhibitor

Tristan Baguet (UGent) , Stef De Lombaerde (UGent) , Jeroen Verhoeven (UGent) , Benedicte Descamps (UGent) , Ingeborg Goethals (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)
Author
Organization
Keywords
ASCT2, PET, Imaging, Tumor

Downloads

  • Poster EMIM Baguet Tristan.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 649.39 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Baguet, Tristan, Stef De Lombaerde, Jeroen Verhoeven, Benedicte Descamps, Ingeborg Goethals, Christian Vanhove, and Filip De Vos. 2018. “Radiosynthesis and in Vivo Evaluation of [18F] FABABA, a New ASCT-2 Inhibitor.” In European Molecular Imaging Meeting, 13th, Abstracts.
APA
Baguet, Tristan, De Lombaerde, S., Verhoeven, J., Descamps, B., Goethals, I., Vanhove, C., & De Vos, F. (2018). Radiosynthesis and in vivo evaluation of [18F] FABABA, a new ASCT-2 inhibitor. European Molecular Imaging meeting, 13th, Abstracts. Presented at the European Molecular Imaging Meeting 2018 (EMIM 2018) ; 13th Annual meeting of the European Society for Molecular Imaging (ESMI).
Vancouver
1.
Baguet T, De Lombaerde S, Verhoeven J, Descamps B, Goethals I, Vanhove C, et al. Radiosynthesis and in vivo evaluation of [18F] FABABA, a new ASCT-2 inhibitor. European Molecular Imaging meeting, 13th, Abstracts. 2018.
MLA
Baguet, Tristan, Stef De Lombaerde, Jeroen Verhoeven, et al. “Radiosynthesis and in Vivo Evaluation of [18F] FABABA, a New ASCT-2 Inhibitor.” European Molecular Imaging Meeting, 13th, Abstracts. 2018. Print.
@inproceedings{8573380,
  author       = {Baguet, Tristan and De Lombaerde, Stef and Verhoeven, Jeroen and Descamps, Benedicte and Goethals, Ingeborg and Vanhove, Christian and De Vos, Filip},
  booktitle    = {European Molecular Imaging meeting, 13th, Abstracts},
  language     = {eng},
  location     = {San Sebasti{\'a}n, Spain},
  title        = {Radiosynthesis and in vivo evaluation of [18F] FABABA, a new ASCT-2 inhibitor},
  year         = {2018},
}